Changes of renal vitamin D metabolic enzyme expression and calcium transporter abundance in obstructive nephropathy

Yan Zhang1, Shu-Yan Wu, Sa-Sa Gu

  • 1Center of System Biomedical Sciences, University of Shanghai for Science and Technology, Shanghai, China. medicineyan@yahoo.com.cn

Insights

Obstructive nephropathy alters renal vitamin D metabolism. Unilateral ureteral obstruction in mice changed expression of vitamin D enzymes and calcium transporters, impacting bone health.

Area of Science:

  • Nephrology
  • Endocrinology
  • Molecular Biology

Background:

  • Urinary tract obstruction's impact on renal function is known.
  • Changes in renal vitamin D metabolism and calcium transport proteins in obstructive nephropathy are poorly understood.

Purpose of the Study:

  • To investigate alterations in renal vitamin D metabolic enzyme and calcium transporter expression in obstructive nephropathy.
  • To explore the relationship between ureteral obstruction and vitamin D-dependent proteins in the kidney.

Main Methods:

  • Unilateral ureteral obstruction (UUO) model in male mice.
  • Kidney tissue analysis using Masson's trichrome staining for fibrosis.
  • Gene expression analysis via reverse transcription-polymerase chain reaction (RT-PCR) and real-time PCR.

Main Results:

  • UUO induced interstitial fibrosis with collagen deposition in obstructed kidneys.
  • Increased 1-hydroxylase (1-OHase) mRNA expression (P < 0.001).
  • Decreased 24-hydroxylase (24-OHase), calcium-binding protein 9kDa (CaBP-9k), and calcium-binding protein 28kDa (CaBP-28k) mRNA expression (P < 0.01) in obstructed kidneys compared to sham.
  • UUO also showed increased 1-OHase and decreased CaBP-9k mRNA in obstructed vs. contralateral kidneys.

Conclusions:

  • Ureteral obstruction alters renal vitamin D metabolic enzyme expression and calcium transporter abundance.
  • These alterations may lead to secondary abnormalities in the vitamin D endocrine system and bone health.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...